Lifeboat Foundation

In the spring, a team of University of Virginia and Virginia Tech scientists shared some exciting news: The vaccine they are developing showed promising results in early animal trials not only for COVID-19, but for other coronaviruses.

If that trend continues through further testing, this vaccine could help contain both current and future variants of the COVID-19 virus — including the Delta variant currently plaguing the United States, and other variants that might crop up in the coming months and years. It could even protect against other coronaviruses, including viruses that cause the common cold. And, it could cost as little as $1 a dose.

What if we had a vaccine that would work for any COVID-19 variants that might pop up – and even for some coronaviruses that cause the common cold? UVA and Virginia Tech scientists are working on it.

Stimulating STEM Innovation & Securing U.S. High-Tech Economy — Kimberly A. Reed, Fmr President and Chairman Export-Import Bank of the United States.

Kimberly A. Reed just finished up a 2-year term as President and Chairman of the Board of Directors of the Export-Import Bank of the United States (EXIM — https://www.exim.gov). She was the first woman to lead EXIM in the agency’s 87-year history, was the first recipient of EXIM’s highest honor, the Franklin D. Roosevelt Award, and was confirmed by the U.S. Senate in 2019 on a strong bi-partisan basis.

Continue reading “Kimberly A Reed — Fmr EXIM Chairman / President — Stimulating STEM & Securing U.S. High-Tech Economy” »

#Israel is on the verge of finalizing a #COVID19 vaccine whose creators believe could offer better protection against variants than its international counterparts such as #Pfizer. In an interview with ‘The Jerusalem Post’, the father of Israel’s BriLife coronavirus vaccine, Prof. Shmuel Shapira, predicted that when the country’s #vaccine is ready, “it will be better” than what its citizens have today.

HEALTH AFFAIRS: The father of the BriLife initiative explains Israel’s strategic imperative to have its own vaccine.

Indeed, as Gizmodo’s report highlights, many experts believe that these researchers have not actually found evidence of dinosaur DNA. They told the news outlet, for example, that—even under the best circumstances—DNA couldn’t last more than three million years. Let alone more than 100 million. And that the chemicals may have been staining inorganic matter that only looks cellular in nature.

As of now, the most ancient DNA that scientists have been able to sequence was that of a million-year-old woolly mammoth. And the youngest dinosaurs are at least 65 million years old. But if future experiments do confirm this evidence as real, then that really changes things. At least in our fantasies, where reanimated dinosaurs and Ian Malcolms abound.

The post Fossil of Peacock-Like Dinosaur May Have Preserved DNA Remnants appeared first on Nerdist.

Residents of Abusir el-Meleq, an ancient Egyptian city south of Cairo, the men died between 1,380 B.C.E. and 450 C.E. A team from Parabon NanoLabs presented the trio’s facial reconstructions at the International Symposium on Human Identification in September.

“[T]his is the first time comprehensive DNA phenotyping has been performed on human DNA of this age,” says Parabon, a Virginia-based company that typically uses genetic analysis to help solve cold cases, in a statement.

To approximate the men’s faces, researchers used DNA phenotyping, which predicts individuals’ physical appearance based on genetic markers. (Phenotyping can suggest subjects’ skin, hair and eye color, but as Caitlin Curtis and James Hereward wrote for the Conversation in 2,018 the process has its limitations.) The team determined the mummies’ other characteristics through examination of their physical remains, reports Hannah Sparks for the New York Post.

Today, the conjunction of climate change, the advent of artificial intelligence and the capacity to import human purposiveness into evolution through the reading and rewriting of our own genome are, like the first leaps in technology and their consequences, stirring a search for the sacred that frames both the limits and potentialities of what it means to be human. As the Polish thinker Leszek Kołakowski sagely put it, without a sense of the sacred, culture loses all sense.

For this reason, he posited in a conversation some years ago at All Souls College in Oxford, that “mankind can never get rid of the need for religious self-identification. … Who am I, where did I come from, where do I fit in, why am I responsible, what does my life mean, how will I face death? Religion is a paramount aspect of human culture. Religious need cannot be excommunicated from culture by rationalist incantation.”

In this, Rees agrees. Far from consigning faith to the past, science fiction plumbs its future. Where technology and its consequences go, the religious imagination will follow.

When Dr. Robert Murphy first started researching biochemistry and drug development in the late 1970s, creating a pharmaceutical compound that was effective and safe to market followed a strict experimental pipeline that was beginning to be enhanced by large-scale data collection and analysis on a computer.

Now head of the Murphy Lab for computational biology at Carnegie Mellon University (CMU), Murphy has watched over the years as data collection and artificial intelligence have revolutionized this process, making the drug creation pipeline faster, more efficient, and more effective.

Recently, that’s been thanks to the application of machine learning—computer systems that learn and adapt by using algorithms and statistical models to analyze patterns in datasets—to the drug development process. This has been notably key to reducing the presence of side effects, Murphy says.

The timeframe for reinfection is fundamental to numerous aspects of public health decision making. As the COVID-19 pandemic continues, reinfection is likely to become increasingly common. Maintaining public health measures that curb transmission—including among individuals who were previously infected with SARS-CoV-2—coupled with persistent efforts to accelerate vaccination worldwide is critical to the prevention of COVID-19 morbidity and mortality.

US National Science Foundation.

And, depending on how further studies progress, it could be implemented via gene therapy.

Early-stage pancreatic cancer has a ‘reset button’

Continue reading “A Biological ‘Time Machine’ With Human Cells Can Help Reverse Cancer” »